Lightnews — Scholar-powered news

BTOG @btog.bsky.social · 1h

💡 Discover the latest in mutation-driven lung cancer research.
Session 4 with @ruthstraussfdn.bsky.social rings science, debate, and progress together.
📅 13 Nov | 📍 The View, London
🔗 www.btog.org/non-smo...
#LungCancer #LCSM #NonSmokingLungCancer

BTOG @btog.bsky.social · 2d

1 week to go!
⏳ The #BTOGScreeningEvent is almost here. Join the lung cancer screening community in London for vital updates, peer discussions, and practical challenges.
Don’t miss it — register today: www.btog.org/btog-sc...
#LungCancer #LCSM

2

BTOG @btog.bsky.social · 7d

"🧩 Local Consolidative Therapy – survival benefits or overtreatment?
Hear from experts tackling difficult questions in non-smoking lung cancer.
🎫 Register today
🔗 www.btog.org/non-smo...
#LungCancer #LCSM #NonSmokingLungCancer
With @RuthStraussFdn"

1 2

BTOG @btog.bsky.social · 7d

Registration and abstract submissions are now open for #BTOG26 our 24th Annual Conference, which will be held at the EICC in Edinburgh.

Full details are on the website www.btog.org/24th-btog-an...

#LCSM #lungcancer

1

Reposted by BTOG

All You Need is Lungs @allyouneedislungs.bsky.social · 9d

Ruth Strauss Foundation have grants up to £50,000 available for research into Non-Smoking #LungCancer; to improve understanding, diagnosis & quality of life 🫁

🗓️ Apply by 10 Jan 2026 #LCSM

ruthstraussfoundation.com/grants-progr...

4 11

Reposted by BTOG

IASLC @iaslc.bsky.social · 9d

♟️ CheckMate for perioperative nivolumab? Dr. Jonathan Spicer presented the latest data from the CheckMate 77T trial at #WCLC25.

🔗 Read more in ILCN: bit.ly/46m612v

Perioperative Nivolumab Proves Safe, Effective for Patients with Resectable Early-Stage NSCLC - ILCN.org (ILCN/WCLC)

Dr. Jonathan Spicer shared patient-reported outcomes data from CheckMate 77T showing the regimen is both safe and tolerable for patients.

bit.ly

1 1

BTOG @btog.bsky.social · 8d

"Psychological distress in screening is real.
How can we recognise & manage it effectively?
Join the discussion at #BTOGScreeningEvent
✅ Full programme: www.btog.org/btog-sc...
#LungCancer #LCSM
"

1 2

BTOG @btog.bsky.social · 13d

"🔍 Brain metastases + the DVLA – treatment implications for your practice.
Don’t miss this timely session in our Advanced Disease module.
📍 London | 📅 13 Nov
#LungCancer #LCSM #NonSmokingLungCancer
🔗 www.btog.org/non-smo...
with @RuthStraussFdn"

2

BTOG @btog.bsky.social · 16d

"Peer support is vital in lung cancer screening delivery.
Our fireside chat will feature first-hand insights from teams on the ground — with real-world Q&A from attendees.
🗓️ 14 Oct 2025 | 💬 Bring your questions!
#LungCancer #LCSM #BTOGScreeningEvent
"

1

BTOG @btog.bsky.social · 20d

"🧠 MRD: Molecular Residual Disease – is it ready for clinical use in early NSCLC?
Get the latest on 13 Nov with @RuthStraussFdn.
🔗 www.btog.org/non-smo...
#LungCancer #LCSM #NonSmokingLungCancer"

1

BTOG @btog.bsky.social · 21d

New Podcast Alert!

BTOG does … Neo-adjuvant / peri-operative chemoimmunotherapy

@tnewsomdavis.bsky.social & Emma O'Dowd talk to Jason Adhikaree.

Subscribe via Apple App Store, Spotify or Amazon Music – just search BTOG or listen via the BTOG website.
www.btog.org/btog-podcasts/
#LCSM #lungcancer

2 3

BTOG @btog.bsky.social · 22d

"Just 4 weeks to go!
Ready to debate hot topics in #LungCancer screening?
Our quick-fire debate session features rapid PRO/CON talks on controversial issues — don’t miss it.
Register now 👉 www.btog.org/btog-sc...
#LCSM #BTOGScreeningEvent
"

1

BTOG @btog.bsky.social · 22d

Durvalumab can only be used if the company provides it according to the commercial arrangement.

For full details and the documents, please see the NICE website www.nice.org.uk/guidance/gid...

Final draft guidance | Project documents | Durvalumab for treating limited-stage small-cell lung cancer after platinum-based chemoradiotherapy [ID5073] | Guidance | NICE

www.nice.org.uk

BTOG @btog.bsky.social · 22d

BTOG wishes to inform members of a new NICE release that has been published today.

NICE has recommended Durvalumab, within its marketing authorisation, as an option to treat limited-stage small-cell lung cancer that has not progressed after platinum-based chemoradiotherapy in adults.
#LCSM

1 1

Reposted by BTOG

National Lung Cancer Audit @nlca-natcan.bsky.social · 27d

📢NLCA has launched a brand new Patient Guide to Statistics📊
This guide is designed to help patients, carers, and the public better understand the numbers and data used by the Audit.
🔗Check it out here: www.natcan.org.uk/library/nlca...

@hqip.bsky.social @btog.bsky.social
#LungCancer #ClinicalAudit

NLCA Patient Guide to Statistics - National Cancer Audit Collaborating Centre

This guide is intended to help patients and the public better understand the numbers and statistics used by the National Lung Cancer Audit to report lung cancer care.

www.natcan.org.uk

1 1 2

BTOG @btog.bsky.social · 27d

"🎯 Targeted therapies in chemoradiotherapy paradigms – how far have we come in managing non-resectable disease?
📅 BTOG Non-Smoking LC Update with @RuthStraussFdn
🗓️ 13 Nov | 📍 London
🔗 www.btog.org/non-smo...
#LungCancer #LCSM #NonSmokingLungCancer"

1

BTOG @btog.bsky.social · 29d

"🔍 Tobacco dependency support in screening: What does optimal delivery look like?
Join us at #BTOGScreeningEvent to hear expert views & engage in live panel Q&A.
Details & booking 👉 www.btog.org/btog-sc...
#LungCancer #LCSM
"

BTOG @btog.bsky.social · Sep 6

The global thoracic oncology community is at #WCLC25 and BTOG is no exception! #LCSM

1

BTOG @btog.bsky.social · Sep 4

"🔬 Session 3: Focus on early and locally advanced disease.
We cover everything from peri-operative strategies to MRD readiness. With @RuthStraussFdn
📆 Register now: 13 Nov
🔗 www.btog.org/non-smo...
#LungCancer #LCSM #NonSmokingLungCancer"

1

BTOG @btog.bsky.social · Sep 4

Remember that BTOG members now receive 30% off IASLC membership as part of our new partnership with IASLC. You also receive a number of other benefits, including discounted admission to WCLC.

BTOG @btog.bsky.social · Sep 4

For the first time BTOG executives, Dawn and Gina, are thrilled to be attending #WCLC25. If you are attending, please visit them at Table Top 6.

1

BTOG @btog.bsky.social · Sep 2

"Explore the impact of screening on lung cancer outcomes in the UK.
Session highlights include data from the NLCA and regional business case modelling.
🗓️ 14 Oct 2025 | 📍 The Minster Building, London
#LungCancer #LCSM #BTOGScreeningEvent
"

BTOG @btog.bsky.social · Aug 28

People having treatment outside this recommendation may continue without change to the funding arrangements in place for them before this guidance was published, until they and their NHS healthcare professional consider it appropriate to stop.

BTOG @btog.bsky.social · Aug 28

This recommendation is not intended to affect treatment with osimertinib that was started in the NHS before this guidance was published.

1

BTOG @btog.bsky.social · Aug 28

epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 L858R substitution mutations, and the cancer has not progressed during or after platinum-based chemoradiotherapy.

1